Published on in Vol 11 , No 5 (2022) :May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/34711, first published .
Efficacy and Tolerability of Two Novel “Standard of Care” Treatments—Intranasal Esketamine Versus Intravenous Ketamine—for Treatment-Resistant Depression in Naturalistic Clinical Practice: Protocol for a Pilot Observational Study

Efficacy and Tolerability of Two Novel “Standard of Care” Treatments—Intranasal Esketamine Versus Intravenous Ketamine—for Treatment-Resistant Depression in Naturalistic Clinical Practice: Protocol for a Pilot Observational Study

Efficacy and Tolerability of Two Novel “Standard of Care” Treatments—Intranasal Esketamine Versus Intravenous Ketamine—for Treatment-Resistant Depression in Naturalistic Clinical Practice: Protocol for a Pilot Observational Study

Gilmar Gutierrez 1 , BSc ;   Joshua Rosenblat 2 , MD ;   Emily Hawken 3 , MSc, PhD ;   Jennifer Swainson 4 , MD ;   Gustavo Vazquez 3 , MD, PhD

1 School of Medicine , Faculty of Health Sciences , Queen's University , Kingston , ON , CA

2 Canadian Rapid Treatment Center of Excellence , Toronto , ON , CA

3 Department of Psychiatry , Faculty of Health Sciences , Queen's University , Kingston , ON , CA

4 Department of Psychiatry , University of Alberta , Edmonton , AB , CA

Corresponding Author:

  • Gustavo Vazquez, MD, PhD
  • Department of Psychiatry
  • Faculty of Health Sciences
  • Queen's University
  • 15 Arch Street
  • Kingston, ON
  • CA
  • Phone: 1 6135444900
  • Email: g.vazquez@queensu.ca